Physician profile
Noam Spinowitz
NPI 1609894005
$73,598.12
in general payments reported to CMS, 2019-2025
13 companies · $15K in 2025
The $15K reported for 2025 was more than what 96% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,248 · 2020: $1,213 · 2021: $8,255 · 2022: $10K · 2023: $15K · 2024: $17K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $47K · Food and Beverage: $791.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $46,833.33 |
| Food and Beverage | $790.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $65,102.03 | 2021-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Medtronic Vascular, INC. | $6,248.10 | 2019 | |
| Covidien LP | $1,145.00 | 2020 | |
| Globus Medical, INC. | $238.12 | 2025 | Senza |
| Medtronic, INC. | $204.51 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $154.10 | 2022-2023 | Xarelto |
| Cardiovascular Systems INC. | $121.58 | 2021-2023 | Diamondback Peripheral |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.88 | 2024 | Jardiance |
| Abbott Laboratories | $83.39 | 2024-2025 | Esprit, Diamondback Peripheral, Jot Dx |
| Becton, Dickinson and Company | $72.28 | 2023-2024 | Pristine |
| Bard Peripheral Vascular, INC. | $68.08 | 2020 | |
| Veryan Medical Incorporated | $27.90 | 2022 | |
| Argon Medical Devices, INC. | $16.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noam Spinowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.